title: Ku70 regulates Bax-mediated pathogenesis in laminin-alpha2-deficient human muscle cells and mouse models of congenital muscular dystrophy.
abstract: The severely debilitating disease Congenital Muscular Dystrophy Type 1A (MDC1A) is caused by mutations in the gene encoding laminin-alpha2. Bax-mediated muscle cell death is a significant contributor to the severe neuromuscular pathology seen in the Lama2-null mouse model of MDC1A. To extend our understanding of pathogenesis due to laminin-alpha2-deficiency, we have now analyzed molecular mechanisms of Bax regulation in normal and laminin-alpha2-deficient muscles and cells, including myogenic cells obtained from patients with a clinical diagnosis of MDC1A. In mouse myogenic cells, we found that, as in non-muscle cells, Bax co-immunoprecipitated with the multifunctional protein Ku70. In addition, cell permeable pentapeptides designed from Ku70, termed Bax-inhibiting peptides (BIPs), inhibited staurosporine-induced Bax translocation and cell death in mouse myogenic cells. We also found that acetylation of Ku70, which can inhibit binding to Bax and can be an indicator of increased susceptibility to cell death, was more abundant in Lama2-null than in normal mouse muscles. Furthermore, myotubes formed in culture from human laminin-alpha2-deficient patient myoblasts produced high levels of activated caspase-3 when grown on poly-L-lysine, but not when grown on a laminin-alpha2-containing substrate or when treated with BIPs. Finally, cytoplasmic Ku70 in human laminin-alpha2-deficient myotubes was both reduced in amount and more highly acetylated than in normal myotubes. Increased susceptibility to cell death thus appears to be an intrinsic property of human laminin-alpha2-deficient myotubes. These results identify Ku70 as a regulator of Bax-mediated pathogenesis and a therapeutic target in laminin-alpha2-deficiency.
authors.affiliation: Neuromuscular Biology & Disease Group, Boston Biomedical Research Institute, 64 Grove Street, Watertown, MA 02478, USA.
authors.forename: Vivek K
authors.initials: VK
authors.lastname: Vishnudas
authors.forename: Jeffrey Boone
authors.initials: JB
authors.lastname: Miller
mesh_terms: D000107:Acetylation; D000328:Adult; D000818:Animals; D034961:Antigens, Nuclear / Q000235:genetics / Q000378:metabolism*; D002478:Cells, Cultured; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D007223:Infant; D000072200:Ku Autoantigen; D034904:Lamin Type A / Q000172:deficiency* / Q000235:genetics; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D018485:Muscle Fibers, Skeletal / Q000378:metabolism; D018482:Muscle, Skeletal / Q000378:metabolism* / Q000473:pathology; D009136:Muscular Dystrophies / Q000151:congenital / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D011485:Protein Binding; D055815:Young Adult; D051028:bcl-2-Associated X Protein / Q000235:genetics / Q000378:metabolism*
chemical_list: D034961:Antigens, Nuclear; D004268:DNA-Binding Proteins; D034904:Lamin Type A; D051028:bcl-2-Associated X Protein; C000606509:Xrcc6 protein, human; C000606510:Xrcc6 protein, mouse; D000072200:Ku Autoantigen
references.citation: Development. 1993 Mar;117(3):1125-33
references.pmid: 8391976
references.citation: Mol Cell Biol. 2007 May;27(9):3511-20
references.pmid: 17325036
references.citation: Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5117-22
references.pmid: 18362350
references.citation: J Biol Chem. 2004 May 7;279(19):19948-54
references.pmid: 15004018
references.citation: Exp Mol Med. 2007 Feb 28;39(1):8-13
references.pmid: 17334224
references.citation: Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11025-30
references.pmid: 12177420
references.citation: J Cell Biol. 1996 Sep;134(6):1483-97
references.pmid: 8830776
references.citation: Nat Med. 2005 Jun;11(6):672-7
references.pmid: 15864313
references.citation: Cancer Res. 2002 Jan 15;62(2):466-71
references.pmid: 11809697
references.citation: J Cell Physiol. 2002 Apr;191(1):69-81
references.pmid: 11920683
references.citation: Neurosci Lett. 2009 Feb 13;451(1):11-5
references.pmid: 19110033
references.citation: Mol Cell Biol. 1992 Jun;12(6):2484-92
references.pmid: 1588952
references.citation: Biochim Biophys Acta. 2006 Sep-Oct;1757(9-10):1301-11
references.pmid: 16836974
references.citation: Biochem Soc Trans. 2007 Aug;35(Pt 4):797-801
references.pmid: 17635151
references.citation: Cell Death Differ. 2007 Dec;14(12):2058-67
references.pmid: 17885668
references.citation: Nat Genet. 2003 Dec;35(4):367-71
references.pmid: 14625552
references.citation: Hum Mutat. 2000;15(1):7-12
references.pmid: 10612815
references.citation: Microsc Res Tech. 2000 Feb 1-15;48(3-4):181-91
references.pmid: 10679965
references.citation: Mol Cell. 2004 Mar 12;13(5):627-38
references.pmid: 15023334
references.citation: Science. 2004 Jul 16;305(5682):390-2
references.pmid: 15205477
references.citation: Hum Mol Genet. 1997 May;6(5):747-52
references.pmid: 9158149
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):991-6
references.pmid: 17215366
references.citation: J Gene Med. 2008 Feb;10(2):217-24
references.pmid: 18074402
references.citation: Eur J Hum Genet. 2002 Feb;10(2):91-4
references.pmid: 11938437
references.citation: J Cell Biol. 1998 Jul 27;142(2):537-44
references.pmid: 9679150
references.citation: Brain. 2009 Jan;132(Pt 1):147-55
references.pmid: 19015158
references.citation: J Clin Invest. 1998 Aug 15;102(4):844-52
references.pmid: 9710454
references.citation: J Clin Invest. 2004 Dec;114(11):1635-9
references.pmid: 15578095
references.citation: Hum Mol Genet. 2005 Apr 15;14(8):1029-40
references.pmid: 15757977
references.citation: Mol Cell Biol. 2008 Oct;28(20):6384-401
references.pmid: 18710944
references.citation: Science. 1995 Oct 6;270(5233):96-9
references.pmid: 7569956
references.citation: J Cell Biochem. 2003 Aug 15;89(6):1115-25
references.pmid: 12898510
references.citation: Trends Mol Med. 2006 Jun;12(6):279-86
references.pmid: 16650805
references.citation: BMC Cell Biol. 2004 Jan 08;5:1
references.pmid: 14711384
references.citation: Ann Neurol. 2009 Jan;65(1):47-56
references.pmid: 19086074
references.citation: Mol Ther. 2006 Jun;13(6):1149-55
references.pmid: 16564230
references.citation: Biochem Biophys Res Commun. 2000 Nov 2;277(3):639-42
references.pmid: 11062006
references.citation: Nat Med. 2008 Apr;14(4):442-7
references.pmid: 18345011
references.citation: Clin Genet. 2008 Dec;74(6):502-12
references.pmid: 18700894
references.citation: J Biol Chem. 1989 Aug 5;264(22):13122-30
references.pmid: 2473986
references.citation: Neurosci Lett. 2004 Nov 30;372(1-2):17-21
references.pmid: 15531080